Journal article

Controlled in vitro delivery of voriconazole and diclofenac to the cornea using contact lenses for the treatment of Acanthamoeba keratitis.

Siân R Morgan, Nicole Pilia, Melissa Hewitt, Rachael L Moses, Ryan Moseley, Philip N Lewis, Peter WJ Morrison, Steven L Kelly, Josie E Parker, David Whitaker, Andrew J Quantock, Charles M Heard

Int J Pharm | Elsevier BV | Published : 2020


Acanthamoeba keratitis is caused by a protozoal infection of the cornea, with 80% of cases involving the improper use of contact lenses. The infection causes intense pain and is potentially blinding. However, early diagnosis improves treatment efficacy and the chances of healing. Despite the apparent accessibility of the cornea, patients do not always respond well to current eye drop treatments largely due to rapid dose loss due to blinking and nasolacrimal drainage. Here, the topical drug delivery of voriconazole alone and in combination with diclofenac via drug-loaded contact lenses, were investigated in vitro. The contact lenses were applied onto excised porcine eyeballs and maintained at..

View full abstract

University of Melbourne Researchers